TrialThe Lancet. Haematology2019

Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial.

Qaiser Bashir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.